Programmable trans-splicing has the potential to transiently alter specific transcripts for both research and therapeutic applications. Here, Chandrasekaran, Tau et al. introduce RESPLICE, which uses two distinct CRISPR effectors to programmatically promote the trans-splicing of a cargo exon into human transcripts while inhibiting cis-splicing.